Supplementary Table 1, Figures 1 - 8 from AURKA Governs Self-Renewal Capacity in Glioma-Initiating Cells Via Stabilization/Activation of Β-Catenin/wnt Signaling

Zhibo Xia,Ping Wei,Heng Zhang,Zhiming Ding,Lixuan Yang,Zhengsong Huang,Nu Zhang
DOI: https://doi.org/10.1158/1541-7786.22509976.v1
2023-01-01
Abstract:PDF file - 2835K, Supplementary Table 1. Differentially regulated Wnt signaling genes by AURKA identified by q-PCR. Supplementary Fig. 1. AURKA and stem cell markers' expressions in mouse model tumor samples. Supplementary Fig. 2. Stem cell markers and differentiation markers were stained after beta-catenin S33Y mutation transfected in stable AURKA knockdown cells. Supplementary Fig. 3. The mRNA levels of beta-catenin in GIC cells that stably expressed control sh-RNA or AURKA-shRNA were detected by q-PCR. Bars from three independent experiments. Supplementary Fig. 4. The stable GSCs that expressed the vector alone and sh-AA-1 were treated with cycloheximide (20 microM) for the indicated time points, and the total proteins were harvested. Supplementary Fig. 5. AXIN siRNA was transiently transfected into the indicated cells using Lipofectamine 2000 in accordance with the manufacturer's instructions. Supplementary Fig. 6. Representative photos of paraffin-embedded specimens of 40 WHO grade IV glioblastomas were stained by immunohistochemistry using anti-AURKA and anti-beta-catenin antibody. Amplifications are 200X; bars represent 200 microM. Supplementary Fig. 7. Cell cycle turnover of GIC cells that stably express control sh-RNA or AURKA-shRNA was decided by flow cytometry. Supplementary Fig. 8. The apoptosis ratio was not influenced after AURKA inhibition in GSC.
What problem does this paper attempt to address?